25/06/2026
In May 2024, the Department of Pharmacy at Pusan National University Hospital (PNUH) pioneered automated pharmacy services in the region by introducing 'KimiBot,' Busan’s first oncology compounding robot. With the recent official launch of its second unit, 'BomiBot,' PNUH has successfully established the region’s only dual-robot system dedicated to chemotherapy preparation.
Oncology compounding robots are state-of-the-art automated systems designed to precisely compound chemotherapy medications within a sterile environment, ensuring that the exact dosage tailored to each patient is prepared safely. The existing 'KimiBot' currently manages approximately 25% of the hospital's total chemotherapy compounding workload. With 'BomiBot' now integrated, the hospital expects to maximize throughput and shorten patient waiting times.
Furthermore, this dual-robot configuration guarantees uninterrupted compounding services during routine equipment maintenance, bolstering both the continuity and safety of cancer care. Both robots feature sterile environments and safety mechanisms that comply with USP 797 and 800 standards, minimizing potential risks during the compounding process. The system also advances the hospital’s ESG initiatives by delivering environmental benefits, notably through the reduction of biomedical waste.
Prior to this, in 2022, PNUH’s Department of Pharmacy became the first in the region to implement an Automated Dispensing System (ADS) for injectables, an automated Total Parenteral Nutrition (TPN) compounder, and an Automated Dispensing Cabinet (ADC) system, consistently driving patient safety and pharmacy service innovation. Furthermore, by fostering certified clinical pharmacists across various specialties, PNUH boasts the largest pool of specialized pharmacy personnel outside the Seoul metropolitan area, delivering top-tier pharmacy services that seamlessly integrate cutting-edge systems with expert human resources.
Moving forward, Pusan National University Hospital remains dedicated to fostering a patient-centered, safe, and precise oncology treatment environment driven by advanced automation and professional pharmaceutical services.